AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 231 filers reported holding AMICUS THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $572,116 | +2055.7% | 57,673 | +2459.8% | 0.01% | +900.0% |
Q1 2024 | $26,540 | -93.0% | 2,253 | -91.6% | 0.00% | -80.0% |
Q4 2023 | $379,610 | +40.4% | 26,752 | +20.3% | 0.01% | -37.5% |
Q3 2023 | $270,450 | +71.7% | 22,241 | +77.3% | 0.01% | +60.0% |
Q2 2023 | $157,515 | +73162.8% | 12,541 | -35.3% | 0.01% | -28.6% |
Q1 2023 | $215 | +481.1% | 19,380 | +550.3% | 0.01% | +250.0% |
Q4 2022 | $37 | -100.0% | 2,980 | -96.6% | 0.00% | -86.7% |
Q3 2022 | $921,000 | +79.2% | 88,209 | +84.6% | 0.02% | +25.0% |
Q2 2022 | $514,000 | +49.9% | 47,790 | +31.7% | 0.01% | +300.0% |
Q1 2022 | $343,000 | +40.0% | 36,282 | +70.8% | 0.00% | -25.0% |
Q4 2021 | $245,000 | -44.4% | 21,248 | -54.0% | 0.00% | -63.6% |
Q3 2021 | $441,000 | +123.9% | 46,173 | +126.6% | 0.01% | +120.0% |
Q2 2021 | $197,000 | -31.8% | 20,380 | -30.5% | 0.01% | 0.0% |
Q1 2021 | $289,000 | -50.5% | 29,323 | +15.9% | 0.01% | -72.2% |
Q4 2020 | $584,000 | +382.6% | 25,308 | +195.6% | 0.02% | +1700.0% |
Q3 2020 | $121,000 | -70.8% | 8,562 | -68.8% | 0.00% | -94.1% |
Q2 2020 | $414,000 | +245.0% | 27,424 | +122.1% | 0.02% | +70.0% |
Q4 2019 | $120,000 | +11900.0% | 12,346 | +12246.0% | 0.01% | – |
Q3 2019 | $1,000 | -99.4% | 100 | -99.2% | 0.00% | -100.0% |
Q3 2018 | $159,000 | +1035.7% | 13,192 | +1297.5% | 0.01% | +500.0% |
Q4 2017 | $14,000 | -84.3% | 944 | -83.9% | 0.00% | -71.4% |
Q3 2017 | $89,000 | – | 5,878 | +16694.3% | 0.01% | – |
Q2 2017 | $0 | – | 35 | +29.6% | 0.00% | – |
Q1 2017 | $0 | -100.0% | 27 | -98.8% | 0.00% | -100.0% |
Q4 2016 | $12,000 | -86.4% | 2,340 | -74.2% | 0.00% | -92.9% |
Q4 2015 | $88,000 | +57.1% | 9,064 | +77.7% | 0.01% | +100.0% |
Q1 2015 | $56,000 | +133.3% | 5,102 | +27.6% | 0.01% | +133.3% |
Q3 2014 | $24,000 | +200.0% | 4,000 | +73.4% | 0.00% | +200.0% |
Q2 2014 | $8,000 | 0.0% | 2,307 | -38.3% | 0.00% | 0.0% |
Q1 2014 | $8,000 | -20.0% | 3,737 | -10.9% | 0.00% | -50.0% |
Q4 2013 | $10,000 | -28.6% | 4,193 | -31.8% | 0.00% | 0.0% |
Q3 2013 | $14,000 | – | 6,151 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 9,029,843 | $89,576,043 | 10.38% |
Perceptive Advisors | 28,057,456 | $278,329,964 | 6.70% |
Redmile Group, LLC | 10,595,089 | $105,103,283 | 6.36% |
STEMPOINT CAPITAL LP | 1,495,047 | $14,830,866 | 4.36% |
CM Management, LLC | 450,000 | $4,464,000 | 4.10% |
Avoro Capital Advisors LLC | 27,400,000 | $271,808,000 | 3.62% |
GREAT POINT PARTNERS LLC | 1,495,500 | $14,835,360 | 2.84% |
Saturn V Capital Management LP | 713,536 | $7,078,277 | 2.68% |
AlphaCentric Advisors LLC | 202,500 | $2,008,800 | 1.48% |
Novo Holdings A/S | 2,500,000 | $24,800,000 | 1.44% |